These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29949532)

  • 1. Anagrelide and the CALR mutation allele burden in essential thrombocythemia.
    Atkinson E; Bakri M; Hayat A; Langabeer SE
    Exp Oncol; 2018 Jun; 40(2):152-153. PubMed ID: 29949532
    [No Abstract]   [Full Text] [Related]  

  • 2. Anagrelide and Mutational Status in Essential Thrombocythemia.
    Iurlo A; Cattaneo D; Orofino N; Bucelli C; Fabris S; Cortelezzi A
    BioDrugs; 2016 Jun; 30(3):219-23. PubMed ID: 27041108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2/CALR/MPL mutational status.
    Mela Osorio MJ; Ferrari L; Goette NP; Gutierrez MI; Glembotsky AC; Maldonado AC; Lev PR; Alvarez C; Korin L; Marta RF; Molinas FC; Heller PG
    Eur J Haematol; 2016 Apr; 96(4):435-42. PubMed ID: 26119186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential thrombocythaemia.
    Double G; Harrison C
    Hematology; 2015 Mar; 20(2):119-20. PubMed ID: 25715049
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world setting.
    Ito T; Hashimoto Y; Tanaka Y; Nakaya A; Fujita S; Satake A; Nakanishi T; Konishi A; Hotta M; Yoshimura H; Ishii K; Hashimoto A; Kondo T; Omura H; Shinzato I; Tanaka T; Nomura S
    Eur J Haematol; 2019 Aug; 103(2):116-123. PubMed ID: 31107982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential Thrombocythemia.
    Tefferi A; Pardanani A
    N Engl J Med; 2019 Nov; 381(22):2135-2144. PubMed ID: 31774958
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened Kidney Function.
    Kwiatkowski J; Kuliszkiewicz-Janus M; Rymer W; Jaźwiec B; Małecki R
    Pharmacology; 2021; 106(5-6):316-322. PubMed ID: 33691325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study.
    Cascavilla N; De Stefano V; Pane F; Pancrazzi A; Iurlo A; Gobbi M; Palandri F; Specchia G; Liberati AM; D'Adda M; Gaidano G; Fjerza R; Achenbach H; Smith J; Wilde P; Vannucchi AM
    Drug Des Devel Ther; 2015; 9():2687-94. PubMed ID: 26028965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutant CALR allele burden in essential thrombocythemia at transformation to acute myeloid leukemia.
    Langabeer SE; Haslam K; Elhassadi E
    Blood Cells Mol Dis; 2017 Jun; 65():66-67. PubMed ID: 28552475
    [No Abstract]   [Full Text] [Related]  

  • 10. [Essential thrombocythemia: therapy with anagrelide].
    Mazzucconi MG; Ferrari A; Balduini CL
    Haematologica; 1991 Jun; 76 Suppl 3():378-81. PubMed ID: 1661268
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of anagrelide in childhood essential thrombocythemia.
    Kanai A; Morokawa H; Matsuda K; Shimazaki E; Nakazawa Y
    Pediatr Int; 2017 Sep; 59(9):1017-1018. PubMed ID: 28707720
    [No Abstract]   [Full Text] [Related]  

  • 12. Essential thrombocythemia: diagnosis and treatment, with special emphasis on the use of anagrelide.
    Andersson BS
    Hematology; 2002 Jun; 7(3):173-7. PubMed ID: 12243981
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of essential thrombocythemia in childhood.
    Scherer S; Ferrari R; Rister M
    Pediatr Hematol Oncol; 2003; 20(5):361-5. PubMed ID: 12775533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.
    Alvarez-Larrán A; Pereira A; Guglielmelli P; Hernández-Boluda JC; Arellano-Rodrigo E; Ferrer-Marín F; Samah A; Griesshammer M; Kerguelen A; Andreasson B; Burgaleta C; Schwarz J; García-Gutiérrez V; Ayala R; Barba P; Gómez-Casares MT; Paoli C; Drexler B; Zweegman S; McMullin MF; Samuelsson J; Harrison C; Cervantes F; Vannucchi AM; Besses C
    Haematologica; 2016 Aug; 101(8):926-31. PubMed ID: 27175028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-induced interstitial pneumonitis in essential thrombocythemia treated with anagrelide].
    Kajiguchi T; Kamoshita S; Ito T; Yagi M; Kimura T
    Rinsho Ketsueki; 2017; 58(2):119-125. PubMed ID: 28321088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of essential thrombocythemia with anagrelide.
    Chintagumpala MM; Kennedy LL; Steuber CP
    J Pediatr; 1995 Sep; 127(3):495-8. PubMed ID: 7658287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet.
    Alvarez-Larrán A; Sant'Antonio E; Harrison C; Kiladjian JJ; Griesshammer M; Mesa R; Ianotto JC; Palandri F; Hernández-Boluda JC; Birgegård G; Nangalia J; Koschmieder S; Rumi E; Barbui T
    Lancet Haematol; 2021 Sep; 8(9):e658-e665. PubMed ID: 34450103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works.
    Inoue S; Okiyama N; Okune M; Shiraki N; Kessoku R; Fujimoto M
    J Dermatol; 2017 Jan; 44(1):84-87. PubMed ID: 27570091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia.
    Mondet J; Park JH; Menard A; Marzac C; Carillo S; Pourcelot E; Girodon F; Cabagnols X; Lodé L; Socoro N; Chauvet M; Bulabois CE; Cony-Makhoul P; Corm S; Cahn JY; Mossuz P
    Haematologica; 2015 May; 100(5):e176-8. PubMed ID: 25661444
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of symptomatic patients with essential thrombocythemia: effectiveness of anagrelide.
    Cacciola RR; Cipolla A; Di Francesco E; Giustolisi R; Cacciola E
    Am J Hematol; 2005 Sep; 80(1):81-3. PubMed ID: 16138352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.